CAR-T Cell Therapy
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
70
NCT04420754
Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 28, 2020
Completion: Aug 4, 2030
Loading map...